Internationally Recognized Thought Leader in Immuno-Oncology Drug Development Brings Nearly Three Decades of Clinical ...
During lactation, the mammary gland undergoes significant structural and functional changes to produce milk, which is ...
If future studies confirm the rescued receptors work normally, the study offers a new roadmap for rare disease drug development.
Leuphasyl (pentapeptide‑18, sequence Tyr‑D‑Ala‑Gly‑Phe‑Leu) emerges as a compelling research tool in neuromuscular and tissue ...
Clinical responses observed in 93 percent of patients at just four weeks in either FricTest Score or Pruritus-NRS, with improvements seen as early as week ...
On Friday 26 th of September, Prof. Mark VON ZASTROW, University of California, San Francisco (UCSF), USA, invited by Prof. Miriam STOEBER will give a lecture entitled "Cellular Organization and ...
In the march of metastasis, a molecular trail of crumbs guides some cancer cells from the primary tumor to establish new ...
Purdue University scientists are deciphering an intricate cellular signaling system critical to immune response to better understand how it could be used to address multiple diseases, including cancer ...
Among the emerging therapeutic strategies for type 2 diabetes (T2D), G protein-coupled receptor 119 (GPR119) agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors have demonstrated promise due to ...
In recent years, it has become evident that cell metabolism shapes and is shaped by immune responses highlighting cell metabolism as therapeutic target to ...
In a major breakthrough, researchers at the Indian Institute of Technology Kanpur (IIT Kanpur) have developed a novel antibody-based biosensor that can monitor the activation of G protein-coupled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback